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Abstract
Regulation of gene expression downstream of the Receptor Tyrosine Kinase signaling pathway in Drosophila relies on a
transcriptional effector network featuring two conserved Ets family proteins, Yan and Pointed, known as TEL1 (ETV6) and
ETS1/ETS2, respectively, in mammals. As in Drosophila, both TEL1 and ETS1/ETS2 operate as Ras pathway transcriptional
effectors and misregulated activity of either factor has been implicated in many human leukemias and solid tumors.
Providing essential regulation to the Drosophila network, direct interactions with the SAM domain protein Mae attenuate
both Yan-mediated repression and PointedP2-mediated transcriptional activation. Given the critical contributions of Mae to
the Drosophila circuitry, we investigated whether the human Ets factors TEL1 and ETS1/ETS2 could be subject to analogous
regulation. Here we demonstrate that the SAM domain of human TEL2 can inhibit the transcriptional activities of ETS1/2 and
TEL1. Drosophila Mae can also attenuate human ETS1/ETS2 function, suggesting there could be cross-species conservation
of underlying mechanism. In contrast, Mae is not an effective inhibitor of TEL1, suggesting the mode of TEL2SAM-mediated
inhibition of TEL1 may be distinct from how Drosophila Mae antagonizes Yan. Together our results reveal both further
similarities and new differences between the mammalian and Drosophila networks and more broadly suggest that SAM
domain-mediated interactions could provide an effective mechanism for modulating output from the TEL1 and ETS1/2
oncogenes.
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Introduction
The evolutionarily conserved Receptor Tyrosine Kinase
(RTK)/Ras/mitogen-activated protein kinase (MAPK) signal
transduction cascade regulates such diverse processes as cell fate
specification, proliferation, differentiation and survival [1]. Con-
sistent with its essential roles in development, misregulation at any
step in the RTK pathway, from the receptor down to the nuclear
transcriptional effectors, contributes to the initiation and progres-
sion of a broad spectrum of human malignancies [2].
Work from multiple laboratories has defined a critical RTK
pathway transcriptional effector circuit in Drosophila in which the
four core components, MAPK, Yan, PointedP2 (PntP2) and Mae,
are interconnected via multiple levels of transcriptional regulation,
protein-protein interactions, and post-translational modifications
(Figure 1A; reviewed in [3]). At the top of this signaling module,
that we will refer to as the E twenty-six (Ets) network, activated
MAPK (or dpERK, dually phosphorylated extracellular signal-
regulated kinase) directly phosphorylates a pair of functionally
antagonistic Ets family transcription factors, Yan and PntP2
[4,5,6]. This attenuates the repressor function of Yan and
stimulates the trans-activation ability of PntP2, thereby effecting
a switch such that target genes previously bound and repressed by
Yan are activated by PntP2. A Sterila Alpha Motif (SAM) domain
containing protein named Modulator of activity of Ets (Mae), itself
a direct transcriptional target of both Yan and PntP2, provides
dual positive and negative feedback regulation by binding directly
to the SAM domains of both Yan and PntP2 and inhibiting their
respective transcriptional activities [7,8,9,10].
Of the four nodes within the Drosophila Ets Network, three have
been identified in mammals: ERK, the Yan ortholog TEL1
(Translocation Ets Leukemia; also referred to as ETV-6, ETS
Variant 6) and the PntP2 orthologs ETS1 and ETS2. Like its
Drosophila counterpart Yan, TEL1 is a transcriptional repressor
whose function is negatively regulated by ERK-mediated phos-
phorylation [11,12], while ETS1 and ETS2, like PntP2, are
activators that require stimulation by dpERK (Figure 1A) [13].
Reflecting their normal developmental roles in regulating prolif-
eration and differentiation in a variety of tissues, misregulated
activity of TEL1 and ETS1/2 provides an oncogenic driving force
for a variety of solid tumors and leukemias [14]. The high degree
of conservation of this signaling module across species is
underscored further by the observation that expression of human
ETS1/2 in Drosophila can partially rescue pnt mutant phenotypes
[15].
In addition to the Ets family DNA binding motif, Yan/TEL1
and PntP2/ETS1/ETS2 all carry a second conserved domain, the
sterile alpha motif (SAM; Figure 1B, C). SAM domains mediate
both homotypic and heterotypic protein-protein interactions, and
are found in a broad spectrum of proteins including a subset of Ets
family members [16,17,18,19]. Both Yan and TEL1 oligomerize
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via their N-terminal SAM domains [11,16,17]. This interaction is
required for transcriptional repression as introduction of missense
mutations that restrict the protein to a monomeric form abrogates
repressor activity [11,16,17,20]. Although Yan/TEL1 monomers
retain DNA binding ability, a recent study showed that
dimerization can confer cooperativity [21]. In the case of TEL1,
chromosomal translocations that fuse the N-terminal SAM
containing region to either protein tyrosine kinases such as
PDGFR (platelet derived growth factor receptor) and Abelson, or
to transcription factors such as AML1 (acute myeloid leukemia)
have been associated with a number of hematopoietic malignan-
cies [14]. The homotypic interaction ability of the TEL1 SAM
domain is thought to contribute to the pathogenesis of these
chimeric fusion proteins [22]. Mae, a monomeric SAM domain
protein, abrogates Yan-mediated transcriptional repression via a
heterotypic MaeSAM-YanSAM interaction that disrupts oligo-
merization in vitro [7,8,17]. Although PntP2/ETS1/ETS2 do not
self-associate via their SAM domains, heterologous SAM-SAM
interactions with Mae abrogate PntP2 activity [7,8,9,10,23].
Despite the multiple layers of critical regulation that Mae
contributes to the Drosophila Ets network, and the extensive
functional conservation between Yan/TEL1 and PntP2/ETS1/2,
to date no mammalian Mae equivalent has been identified. To
address this gap, we investigated whether comparable SAM-
mediated interactions could influence the vertebrate Ets network.
Here we demonstrate that the SAM domain from the human Ets
family member TEL2 can antagonize the transcriptional activities
both ETS1/ETS2 and TEL1. Further, Drosophila Mae can
effectively antagonize human ETS1/2, suggesting cross-species
mechanistic conservation. However Mae is not an effective
inhibitor of TEL1, nor is human TEL2 a strong antagonist of
Drosophila Yan. This suggests that although both Mae-Yan and
Figure 1. Conservation of the mammalian and Drosophila Ets networks. (A) Schematic representation of the Drosophila and Mammalian Ets
Networks. Activated MAPK (dpERK) phosphorylates Yan (TEL1) and PntP2 (ETS1/2) to inhibit transcriptional repression of target genes by Yan and to
potentiate transcriptional activation by PntP2 respectively. Mae negatively regulates Yan and PntP2 to modulate signaling by the RTK network.
Similarly, TEL2SAM negatively regulates the transcriptional activity of the vertebrate orthologs TEL1 and ETS1/2. (B) Sequence alignment of the SAM
domains of Yan, TEL1, TEL2, Mae, PntP2, ETS1 and ETS2. Amino acids that are identical in at least four of the seven proteins are in bold, grey boxes
highlight critical residues that mediate EH-ML surface interactions, and the asterisks indicate the specific residues mutated in the TEL2SAMEHmut and
TEL2SAMMLmut constructs. (C) Dendrogram analysis using the sequences in (B) shows the phylogenetic relationships of the SAM domains.
doi:10.1371/journal.pone.0037151.g001
Tel2SAM Blocks Tel1 and Ets1/2 Activity
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TEL2-TEL1 interactions can abrogate transcriptional repression
activity, the underlying mechanisms may be distinct. More
broadly, our results suggest that further exploration of SAM-
mediated inhibitory interactions could lead to development of
therapeutic reagents that attenuate the oncogenic activities of
human Ets proteins.
Materials and Methods
Plasmids
For expression in Drosophila cultured cells ETS1, ETS2 and
TEL2 were PCR amplified using 59ETS1-KpnI aagggtac-
caaggcggccgtcgat, 39 ETS1-SacI aagagctcctagtcagcatccggctt,
59ETS2-Sal1 gaggtcgaccaatgactttggaatc, 39ETS2-Not1
aagcggccgctcagtcttctgtatcaggc, 59TEL2-Kpn1 aagggtacccaggagg-
gagaattgg, 39TEL2-Sal1 gaggtcgactcacggagagatttctggc from
pCMVTag2a-ETS1, pCMVTag2a-ETS2, pMSCV-FlagTEL2-I-
GFP plasmids respectively and cloned into pRmHa3-Flag vector.
The argos-luciferase reporter was generated by PCR amplification
using 59 arg-KpnI ggggtacctaacggtgatgtctttg and 39arg-NdeI
gcaattccatatgataccggaagtccggaagtg from genomic DNA and
cloned upstream of the luciferase ORF. ETS1, ETS2 expression
plasmids, MMP9 and dEtsluciferase reporter plasmids were
provided by Dr. Barbara Graves and TEL1 and TEL2 constructs
by Dr. Gerard Grosveld. For expression in HeLa cells, TEL1 and
TEL2 were subcloned as EcoRI fragements from pMSV-ttTel and
pMSCV-FlagTEL2-I-GFP respectively into pCDNA3.1. TEL2-
SAM (1–117aa) was generated by PCR amplification using
39TEL2-XhoI (117aa) catctcgagttaccgctgggtcttgatgt and cloned
into pCDNA3.1. TEL2SAMMLmut and TEL2SAMEHmut were
generated using site directed mutagenesis.
Transfection and Transcription assays
Drosophila cultured S2 cells obtained from the Drosophila
Genomics Resource Center were grown in Gibco Sf-900 serum-
free medium (Invitrogen) and transfected using DDAB with 1.0 ug
of argos-luciferase reporter, 2.0 mg of expression plasmids and
0.5 mg of pActLacZ to normalize for transfection efficiency. HeLa
cells obtained from the ATCC (CCL-2) were cultured in MEM
supplemented with 10% fetal bovine serum and transfected using
lipofectamine with 0.5 mg of MMP9-luciferase and dEts-luciferase
reporters, 1.0 mg of expression plasmids and 200 ng of Renilla
luciferase to normalize for transfection efficiency. To analyze
TEL1 repression HeLa cells were transfected with 2.0 mg of
E74tkLuciferase, 200 ng of Renilla luciferase and 1.0 mg of the
respective expression plasmids. Transcription assays were per-
formed using the luciferase and Galacto star kits (Tropix) for
Drosophila cultured cells and the Dual luciferase assay system
(Promega) for HeLa cells.
Co-immunoprecipitations
Drosophila cultured cells were lysed by sonication in lysis buffer
(50 mM Tris pH 7.5, 100 mM NaCl, 2 mM EDTA, 2 mM
EGTA, 1% NP40). Clarified lysates were incubated with 20.0 ul of
Flag conjugated agarose beads for 3 hours at 4uC, washed
365 min in lysis buffer and run on 8 or 12% SDS polyacrylamide
gels. HeLa cells were lysed by sonication in lysis buffer (50 mM
Figure 2. TEL2SAM inhibits transcriptional repression by TEL1
of the E74tkluciferase reporter. (A) Repression by TEL1 is
suppressed by TEL2SAM but Drosophila Mae has only a weak effect.
The full-length TEL2 alone lane derives from an independent
experiment in which repression by TEL1 was almost identical to that
shown here. Using the TEL1 alone values to normalize between
experiments, the % transcriptional activity for TEL2 was adjusted by a
factor of 0.82. (B) TEL2SAM effectively inhibits repression by TEL1 at
decreasing TEL2SAM concentrations. The ratio of TEL2SAM DNA to TEL1
DNA that was used for titration ranged from 2:1 to 0.25:1.
doi:10.1371/journal.pone.0037151.g002
Figure 3. Inhibition of TEL1 repression by TEL2SAM is alleviated by mutations that prevent SAM domain-polymerization. (A)
Communoprecipitation of myc-TEL2SAM with HA-TEL1 from cotransfected HeLa cells (lane 2) but not from cells transfected with HA-TEL1 alone (lane
1). Top and bottom panels were from the same gel, as were the middle two panels. (B) TEL2SAM can inhibit transcriptional repression by Yan,
although not as effectively as Mae. (C) Repression of the E74tkluciferase reporter by TEL1 is suppressed by TEL2SAM but not by TEL2SAMEHmut or
TEL2SAMMLmut.
doi:10.1371/journal.pone.0037151.g003
Tel2SAM Blocks Tel1 and Ets1/2 Activity
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Tris pH 7.5, 100 mM NaCl, 1 mM EDTA, 1% Triton-X).
Lysates were incubated with 15.0 ul Myc agarose beads overnight
at 4uC, followed by 365 min washes in wash buffer (50 mM Tris
pH 7.5, 100 mM NaCl, 1 mM EDTA, 0.25% Triton-X) and run
on 8 or 15% SDS polyacrylamide gels. The following antibodies
were used for western blotting, Rba Flag 1:5000 (Sigma), maMyc
1:1000 (Santa Cruz Biotechnology) and Rba HA 1:5000 (Rock-
land).
Results and Discussion
TEL2SAM can inhibit transcriptional repression by TEL1
Considering the structural and functional similarities between
the Yan and TEL1 repressors, together with the pivotal regulation
provided by Mae with respect to Yan, we speculated that a Mae-
like protein might similarly regulate TEL1 activity. Another Ets
family member, human TEL2, provided an intriguing candidate
as it has been shown to interact with and antagonize the ability of
TEL1 to inhibit Ras induced cellular transformation, although the
underlying mechanism has not been elucidated [24,25]. Of further
interest is a splice isoform, TEL2a, that is predicted to encode a
protein consisting of only the N-terminal SAM domain [26],
which would be structurally quite similar to Drosophila Mae. We
therefore postulated that human TEL2 might provide a functional
counterpart to Drosophila Mae by interacting with and inhibiting
TEL1-mediated transcriptional repression.
To address this question we performed transcription assays in
transiently transfected HeLa cells and examined the ability of
TEL1 to repress the E743tkluciferase reporter [11] in the presence
and absence of either full-length TEL2 or TEL2SAM, a construct
designed to mimic both TEL2a and Mae. Like TEL1, both TEL2
and TEL2SAM were predominantly nuclear as judged by indirect
immunofluorescence, and western blot analysis confirmed expres-
sion of products of the expected size (data not shown). Expression
of TEL1 or TEL2 alone resulted in respective five-fold and three-
fold repression of the E743tkluciferase reporter, while TEL2SAM
alone, which lacks a DNA binding domain, had no effect
(Figure 2A and data not shown). Co-expression of TEL2SAM
almost completely attenuated transcriptional repression by TEL1,
while coexpression of full-length TEL2 with TEL1 resulted in a
level of repression (2.5-fold) comparable to that of TEL2 alone
(Figure 2A). Because interpreting the results with full length TEL2
is complicated by the fact that TEL29s intrinsic repression ability
could mask the effects of direct SAM domain-mediated interfer-
ence with TEL1 function, all subsequent experiments were
performed with the TEL2SAM construct.
Because the TEL2a isoform has been reported to be expressed
at low levels [26], we reduced the levels of TEL2SAM in our assay
system to more accurately reflect the presumed physiological
situation in which TEL2a would be present in substoichiometric
ratio to TEL1. Our results revealed effective inhibition of TEL1-
mediated repression even when the amount of TEL2SAM DNA
used for transfection was 0.25 times that used for TEL1
(Figure 2B). This suggests the functional interactions observed in
transfected cells should be possible in situ, and emphasizes the
importance of developing suitable reagents to explore interactions
between endogenous TEL2a and TEL1 in normal and malignant
tissues.
Distinct mechanisms of TEL2SAM inhibition of TEL1 and
Mae inhibition of Yan
The ability of TEL2SAM to inhibit TEL1-mediated transcrip-
tional repression suggests TEL2SAM could provide a functional
counterpart to Drosophila Mae. Consistent with this hypothesis, co-
immunoprecipitation experiments revealed association of the
TEL2SAM and TEL1 (Figure 3A). This suggests that abrogation
of TEL1-mediated repression results from heterodimeric TEL1-
TEL2SAM interactions, just as SAM-mediated Yan-Mae com-
plexes have been shown to attenuate Yan repression activity.
To determine the extent of cross-species conservation, we asked
whether Mae could inhibit TEL1 and whether TEL2SAM could
inhibit Yan. Unexpectedly, Drosophila Mae only modestly attenu-
ated TEL1-mediated repression (Figure 2A). Mae was not simply
misfolded and inactive in the HeLa cell environment because it
could completely attenuate Yan-mediated repression of the same
reporter (Figure 3B). TEL2SAM was able to inhibit Yan-mediated
repression, although it was less effective than Mae (Figure 3B).
These results demonstrate that the SAM domains of both human
TEL2 and Drosophila Mae share the ability to attenuate TEL1/
Yan-mediated repression. However the inability of Mae to
antagonize TEL1 and the reduced ability of TEL2SAM to
antagonize Yan suggest the underlying mechanisms could be
different.
Mechanistically, because the SAM domain of TEL2 can itself
oligomerize, it has been proposed that it might form a copolymer
with TEL1 [16,19,27]. This is in contrast to Drosophila Mae, where
replacement of one of the key hydrophobic residues in the EH
surface with a negatively charged aspartate (Figure 1B) prevents
the EH-ML interaction and limits the protein to a monomeric
state. Mae retains a functional ML surface and so can form
heterodimers, but not hetero-oligomers, with Yan. By ‘‘capping’’
the extent of Yan polymerization, Mae thus attenuates Yan’s
repression activity [27].
Because Drosophila Mae was an ineffective TEL1 antagonist, we
hypothesized that TEL1-TEL2SAM heteropolymerization might
contribute to abrogation of TEL1-mediated repression. Consistent
with this interpretation, mutation of a conserved residue in either
the EH or ML domain of TEL2SAM that is predicted to interfere
with SAM domain mediated interactions [17], produced a
TEL2SAM protein that was unable to inhibit repression by
TEL1 (Figure 3C). Together our results demonstrate that SAM-
mediated interactions with TEL2 can antagonize TEL1-mediated
repression activity, but that the underlying mechanism appears
distinct from how Mae antagonizes Yan activity. Further
biochemical analysis will be required to reveal the precise
mechanisms and stoichiometry of TEL1-TEL2 and TEL1-
Figure 4. Mae suppresses transcriptional activation by ETS1/2
in Drosophila S2 cells. (A) Activation of the argos-luciferase reporter
by ETS1/2 is enhanced by expression of RasV12 and inhibited by Mae. (B)
Myc-Mae coimmunoprecipitated with Flag-ETS1/2 from lysates of
cotransfected Drosophila S2 cells cotransfected (lanes 2 and 3) but
not from lysates of cells transfected with Myc-Mae alone (lane 1). Myc-
Mae runs below the IgG light chain (strong band marked with asterisk).
Flag-ETS1/2 run as doublets.
doi:10.1371/journal.pone.0037151.g004
Tel2SAM Blocks Tel1 and Ets1/2 Activity
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TEL2SAM interactions and to explain why TEL2-TEL1 hetero-
polymers should be less effective repressors than TEL1 homopol-
ymers.
Could other SAM domain proteins also negatively regulate
TEL1 function? The fact that the TEL2 gene is deleted in rodents,
and even in humans is unlikely to be universally coexpressed with
TEL1 [26], suggests the likelihood of functionally redundant
mechanisms. Thus a broader investigation of SAM-mediated
inhibition of TEL1 activity may be warranted. While such
regulation need not derive solely from other Ets family members,
SAM-mediated protein-protein interactions between Tel-1 and
Fli-1 have been reported [28]. Two charged residues in the ML
region of the Fli-1SAM domain are predicted to interfere with its
self-association, consistent with its placement in the subset of
monomeric Ets family members. However, while Tel-1 has been
shown to interfere with the ability of Fli-1 to function as a
transcriptional activator [28], whether Fli-1 can antagonize Tel-1
mediated repression has not yet been investigated. Similarly in
Drosophila, investigation of potential regulation of Yan via
heteropolymeric interactions with other SAM containing proteins
could prove fruitful.
Negative regulation of ETS1/ETS2 by Mae and TEL2SAM
Drosophila Mae provides both positive and negative feedback
regulation within the Ets Network [10]. Thus in addition to
facilitating down-regulation of Yan-mediated repression to allow
PntP2 to activate key downstream target genes, Mae attenuates the
transcriptional response to RTK signaling by associating with
PntP2 and blocking its MAPK docking site, thereby preventing
phosphorylation-induced activation [23]. As with the Yan-Mae
interaction, the PntP2-Mae interaction occurs via their respective
SAM domains [8,9,23]. Like PntP2, mammalian ETS1 and ETS2
are nuclear effectors of RTK signaling that are activated by
MAPK-mediated phosphorylation of a conserved threonine
residue N-terminal to the SAM domain (Figure 1A) [4,5,13].
Given the structural and functional similarities between PntP2 and
ETS1/2, we asked whether Mae could abrogate transcriptional
activation by ETS1 and ETS2.
We addressed this question first by following transcriptional
reporter expression in transfected Drosophila S2 cells, an assay
system that we and others have exploited previously to elucidate
Mae function with respect to PntP2 [8,9,23]. Using argos-
luciferase, a reporter construct derived from a Yan and PntP2
responsive regulatory element from the transcriptional target argos
[29], we analyzed the ability of ETS1 and ETS2 to activate
transcription in S2 cells. Further demonstrating their functional
similarity to PntP2 [5,8,15], both ETS1 and ETS2 activated the
reporter in a manner that was enhanced by co-expression of
constitutively active Ras (RasV12) (Figure 4A). Addition of Mae
effectively repressed Ras/MAPK stimulated transcriptional acti-
vation by ETS1 and ETS2 (Figure 4A) and co-immunoprecipi-
tation experiments demonstrated that Mae could interact with
both proteins (Figure 4B).
To assess further Mae-mediated negative regulation of ETS1
and ETS2, we examined the ability of Mae to prevent
transcriptional activation of native Ets target genes by performing
transcription assays in transiently transfected HeLa cells. Two
transcriptional reporters, MMP9-luciferase and dEts-luciferase,
that contain Ras responsive elements (RRE) from the regulatory
regions of the ETS1/ETS2 target genes MMP9 and MMP3, were
assayed [30]. As in S2 cells, Mae effectively prevented Ras
stimulated transcriptional activation by ETS1 and ETS2
(Figure 5A, 5B). Together these results suggest that the mechanism
of Mae-mediated antagonism of PntP2 in Drosophila [8,9,23] could
be relevant to ETS1/ETS2 regulation in mammals.
The activities and regulation of ETS1 and ETS2 were slightly
different in the two cell types that were used for our analysis. In S2
cells, we observed higher levels of luciferase reporter activation by
ETS1 than ETS2 (Figure 4A), whereas in HeLa cells ETS2 was a
more efficient activator (Figure 5A, 5B). This might reflect a
difference in the ability of Mae to interact with and negatively
regulate ETS1 and ETS2. Supporting this idea, Mae was more
efficiently immunoprecipitated by ETS2 than by ETS1 (Figure 4B,
compare lane 3 and lane 2) even though it was expressed at
comparable levels. Since Mae is expressed endogenously in S2
cells, the lower activation by ETS2 might be a result of inhibition
Figure 5. TEL2SAM inhibits transcriptional activation by ETS1/2 in HeLa cells. RasV12 enhanced and Mae or TEL2SAM suppressed activation
of (A) the MMP9-luciferase reporter and (B) the dEts-luciferase reporter. (C) Mutations in the EH or ML surfaces of TEL2SAM do not alter its ability to
suppress ETS2.
doi:10.1371/journal.pone.0037151.g005
Tel2SAM Blocks Tel1 and Ets1/2 Activity
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by endogenous Mae. Also, Mae was able to negatively regulate
ETS1/2 more effectively in S2 than in HeLa cells, perhaps
reflecting reduced functionality of the Drosophila protein at the
higher temperature used for culturing HeLa cells. Alternatively,
endogenous ETS1/ETS2 proteins in HeLa cells could interact
with Mae and limit its ability to repress function of the
overexpressed constructs.
We next asked whether TEL2SAM could function analogously
to Mae by analyzing the effect of TEL2SAM on ETS1/2-
mediated activation of the MMP9 and dEts-luciferase reporters.
TEL2SAM was able to prevent Ras stimulated transcriptional
activation of both reporters by ETS1 and ETS2 (Figure 5A,B).
Furthermore, TEL2SAM oligomerization was not required, as EH
or ML surface mutations did not compromise activity (Figure 5C).
Thus TEL2SAM behaves similarly to Drosophila Mae with respect
to antagonism of ETS1/2 transcriptional activity. Future bio-
chemical analyses will be needed to determine whether TEL2-
SAM negatively regulates ETS1/2 function by blocking the
MAPK phosphorylation site, just as has been previously shown in
the Mae-PntP2 interaction [23], or whether it acts via a different
mechanism.
In conclusion, our work predicts that SAM-mediated interac-
tions are likely to modulate the activity of mammalian TEL1 and
ETS1/ETS2, as has been previously shown for the Drosophila
homologs Yan and PntP2. Because misregulated activity of both
TEL1 and ETS1/2 provides an oncogenic driving force for a
variety of solid tumors and leukemias [14], the ability of
TEL2SAM to antagonize ETS1/2 and TEL1 function suggests
that assaying the presence or absence of the TEL2a isoform might
be a useful diagnostic tool for predicting which malignancies
retained or lacked this putative regulatory mechanism. Ultimately,
our work may provide a foundation for designing therapeutic
reagents that block the oncogenic function of TEL1 and ETS1/2.
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